Search results
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease of variable severity and course, characterised by a tendency for flare (figure 1).1 In SLE, both innate and adaptive immune responses are involved.
El lupus eritematoso sistémico (LES) es una compleja enfermedad reumática multisistémica de ori-gen autoinmune con una morbimortalidad importantes. Es una de las enfermedades autoinmunes más comunes, con una prevalencia estimada de 20-150/100.000 habitantes.
1 sty 2021 · Systemic Lupus Erythematosus. Article PDF Available. A Review of Systemic Lupus Erythematosus (SLE): Symptoms, Risk Factors, Treatment, and Health Related Quality of Life Issues. January 2021....
17 kwi 2024 · Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease, characterised by the presence of autoantibodies towards nuclear antigens, immune complex deposition, and chronic inflammation at classic target organs, such as skin, joints, and kidneys.
Systemic lupus erythematosus (SLE) is a multisystem chronic autoimmune disease with a relapsing and remitting course. Its prevalence is higher in women of childbearing age, with a female predominance of 9:1 [1]. The exact etiology of this disease is not understood well.
Systemic Lupus Erythematosus. An inflammatory, multisystem, autoimmune disease of unknown etiology with protean clinical and laboratory manifestations and a variable course and prognosis. Lupus can be a mild disease, a severe and life-threatening illness, or anything in between.
Systemic lupus erythematosus (SLE) is a multisystem dis-ease with a highly variable course. Management is complex and involves clinicians across many different specialties, with important variations in practice apparent across and within these specialties.
